Tamyo Mbisa
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, HIV Research and Treatment, Hepatitis C virus research
Most-Cited Works
- → MAIT cells are activated during human viral infections(2016)512 cited
- → Interferon lambda 4 impacts the genetic diversity of hepatitis C virus(2019)146 cited
- → Persistence of HIV-1 Transmitted Drug Resistance Mutations(2013)111 cited
- → Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure(2021)22 cited
- → A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus(2019)20 cited
- → Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study(2020)15 cited
- → Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV(2019)10 cited
- → Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction(2018)8 cited
- → Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance(2018)7 cited
- → Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus(2019)2 cited